The 2026 Assessment Deadline
By 2026, CDC wants to map every risk across their entire portfolio. They are looking at how assets depend on local nature. This is not a slow rollout. It is a full scale audit of dependencies and risks.
Mandatory BiodiverCity Labels
Every new development at CDC must get this certification. It applies to renovations too. If you are a developer or a partner, you cannot skip this step. 100% compliance is the target for the whole group.
Measuring Mean Species Abundance
CDC uses the Global Biodiversity Score or GBS. This tool measures the impact on species per square kilometer. It gives them a hard number to track. They want to see real data. Vague promises about "green space" are no longer enough.
Reaching Zero Net Artificialisation
This aligns with the ZAN goal in France. CDC tracks how much land they seal versus how much they restore. They use the Nature 2050 program to fund these solutions. It is about balancing the books on land use at the asset level.
Leading GRESB and CSRD
CDC is setting the pace for CSRD and TNFD reporting. Their subsidiaries like Icade and Covivio are already at the top of the GRESB rankings. They are prove that biodiversity data is now a core part of financial performance.
Next Steps for Your Portfolio
Check if your current projects meet the BiodiverCity standard now. If you want to work with CDC or its subsidiaries, you need a plan for ZAN and measurable species data.
Need to align your portfolio with these standards? Book a call with us to get started on measuring your nature data.
Learn how other real estate funds such as AP2 and APG approach biodiversity.
